- Home
- GV vs IMRN Comparison
GV vs IMRN Comparison
Compare GV & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GV
- IMRN
- Stock Information
- Founded
- GV 2013
- IMRN 1994
- Country
- GV Canada
- IMRN Australia
- Employees
- GV N/A
- IMRN N/A
- Industry
- GV Other Consumer Services
- IMRN Biotechnology: Pharmaceutical Preparations
- Sector
- GV Real Estate
- IMRN Health Care
- Exchange
- GV Nasdaq
- IMRN Nasdaq
- Market Cap
- GV 7.8M
- IMRN 9.2M
- IPO Year
- GV 2022
- IMRN N/A
- Fundamental
- Price
- GV $1.77
- IMRN $1.88
- Analyst Decision
- GV
- IMRN Strong Buy
- Analyst Count
- GV 0
- IMRN 1
- Target Price
- GV N/A
- IMRN $5.00
- AVG Volume (30 Days)
- GV 33.6K
- IMRN 25.5K
- Earning Date
- GV 08-14-2025
- IMRN 07-07-2025
- Dividend Yield
- GV N/A
- IMRN N/A
- EPS Growth
- GV N/A
- IMRN N/A
- EPS
- GV N/A
- IMRN N/A
- Revenue
- GV $7,773,905.00
- IMRN $4,048,286.00
- Revenue This Year
- GV N/A
- IMRN N/A
- Revenue Next Year
- GV N/A
- IMRN N/A
- P/E Ratio
- GV N/A
- IMRN N/A
- Revenue Growth
- GV N/A
- IMRN 82.90
- 52 Week Low
- GV $1.00
- IMRN $1.50
- 52 Week High
- GV $9.60
- IMRN $2.87
- Technical
- Relative Strength Index (RSI)
- GV 41.00
- IMRN 58.70
- Support Level
- GV $1.72
- IMRN $1.68
- Resistance Level
- GV $1.90
- IMRN $1.94
- Average True Range (ATR)
- GV 0.11
- IMRN 0.09
- MACD
- GV -0.01
- IMRN 0.02
- Stochastic Oscillator
- GV 12.50
- IMRN 76.92
About GV Visionary Education Technology Holdings Group Inc.
Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.